⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Official Title: Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Study ID: NCT04904146

Study Description

Brief Summary: A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

Lund University Hospital, Lund, , Sweden

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: